SLC5A2 and diabetic kidney disease: Results of previous clinical trials suggested that glomerular hyperfiltration driven by the activation of SGLT2 and the renin-angiotensin-aldosterone system (RAAS) is the possible pathomechanism of diabetic nephropathy.